Nouhad Husseini

Senior Vice President, Business Development · Regeneron Pharmaceuticals

Biopharmaceuticals

Nouhad Husseini is senior vice president of business development at Regeneron Pharmaceuticals. He joined in 2011 and oversees strategic collaborations and licensing agreements, drawing on earlier business development, corporate finance, investment banking and equity research experience.

Last reviewed: Oct 21, 2026

Nouhad Husseini

Senior Vice President, Business Development Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Nouhad Husseini is senior vice president of business development at Regeneron Pharmaceuticals. He joined in 2011 and oversees strategic collaborations and licensing agreements, drawing on earlier business development, corporate finance, investment banking and equity research experience.

Career Highlights

  • Joined Regeneron in 2011.
  • Oversees strategic collaborations and licensing agreements.
  • Previously worked at Genentech, Morgan Stanley and Robertson Stephens.

Professional Journey

Husseini’s career combines scientific education with finance and business development. His earlier experience includes investment banking and equity research at Morgan Stanley and Robertson Stephens, followed by roles in Genentech’s Business Development and Corporate Finance departments.

He joined Regeneron in 2011. As senior vice president and head of Business Development, he oversees efforts to establish strategic collaborations and licensing agreements. The company biography describes a background spanning strategy, business development and finance within the biopharmaceutical industry.

His work brings that experience into the partnerships supporting Regeneron’s scientific and business priorities. The company’s collaborations page also identifies him in the business development role. His current remit is not used to attribute every corporate partnership or acquisition to him personally; the reviewed primary sources establish responsibility for the function rather than a record of individually executed transactions.

Education

Husseini earned an undergraduate degree in molecular biology from Princeton University and an MBA from the University of Pennsylvania’s Wharton School.